Discovery And Technology Converging To Create Next-Generation Therapies In Reproductive Medicine

Main Category: Women's Health / Gynecology
Also Included In: Fertility;  Sexual Health / STDs
Article Date: 22 Aug 2006 - 14:00 PDT

email to a friend   printer friendly   opinions  

Greystone Associates Analyzes Evolving Therapeutic Landscape

(Amherst, NH) - The convergence of target-specific biological drugs, formulation science, and patient-friendly delivery technology are creating therapeutic opportunities that will have a significant impact on the practice of female reproductive medicine. This evolution in care is occurring at a time when women in virtually every age group are struggling to cope with real or perceived medical conditions. From the side effects of hormone replacement therapy to the life-style driven increase in the incidence of HPV and infertility, women are seeking answers to their medical needs from a healthcare industry that has been sending hopeful, albeit sometimes confusing, messages.

With the increasing availability of drugs that improve therapeutic outcomes and in some cases address previously untreatable conditions, opportunities for participants in the reproductive medicine sector are starting to emerge. Recombinant proteins that produce powerful metabolic responses are replacing small-molecule drugs. Novel formulation strategies and delivery technologies are contributing to growth prospects by reducing dosing frequency, minimizing patient administration requirements and improving compliance. These developments will lead to strong growth in industrialized regions, as a growing number of women in these countries seek therapeutic solutions to gender-specific conditions.

These findings are contained in a new and comprehensive report. The report - Reproductive Medicine: Emerging Therapeutics, Expanding Opportunities - contains in-depth analysis of the drugs, pipeline candidates, technology, and market participants that are shaping the future of female reproductive medicine.

More information is available at
http://www.greystoneassociates.org

About Greystone

Greystone Associates is a medical and healthcare technology consulting firm providing services in strategic planning, venture development, product commercialization, and technology assessment.

• Additional
• References
• Citations